European Pediatric Catheter Ablation Registry
EUROPA
1 other identifier
observational
N/A
4 countries
6
Brief Summary
The main objective of the European Pediatric Catheter Ablation Registry is to collect data on ablation procedures in the European pediatric population in order to improve the management of this subset of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2012
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 11, 2012
CompletedFirst Posted
Study publicly available on registry
September 24, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedSeptember 25, 2012
September 1, 2012
4 years
September 11, 2012
September 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To collect data on ablation procedures in the European pediatric population.
Primary outcome will be a combination of efficacy (arrhythmia recurrency) and safety (procedural and late complications)
After 12 months from the ablation procedure
Secondary Outcomes (1)
To describe and compare different ablation methodologies
After 12 months from the ablation procedure
Eligibility Criteria
European pediatric population
You may qualify if:
- Pediatric patients scheduled to any kind of an ablation procedure;
- Patient´s age between 0 and 18 years;
- Legal guardians understand the nature of the procedure, are willing to comply with study follow-up evaluations, and provide written informed consent prior to the procedure.
You may not qualify if:
- Patient unable to comply with follow-up schedule;
- Patient has medical conditions that preclude protocol compliance or limit study participation;
- Legal guardian or patient unwilling or unable to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
University Hospital Motol
Prague, 150 00, Czechia
Herzzentrum Leipzig GmbH
Leipzig, 04289, Germany
Ospedali Riuniti di Bergamo
Bergamo, BG, 24128, Italy
Ospedali Manzoni
Lecco, LE, 23900, Italy
Ospedale S. Raffaele
Milan, MI, 20132, Italy
Leiden University Medical Center
Leiden, 2300, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francesco Cantù, MD
Ospedale Manzoni, Via dell'Eremo 9/11 23900 Lecco, Italy.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 11, 2012
First Posted
September 24, 2012
Study Start
July 1, 2012
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
September 25, 2012
Record last verified: 2012-09